Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

A comparison of the risk of QT prolongation among SSRIs.

Funk KA, Bostwick JR.

Ann Pharmacother. 2013 Oct;47(10):1330-41. doi: 10.1177/1060028013501994. Epub 2013 Oct 21. Review.

PMID:
24259697
[PubMed - indexed for MEDLINE]
2.

Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation.

Beach SR, Kostis WJ, Celano CM, Januzzi JL, Ruskin JN, Noseworthy PA, Huffman JC.

J Clin Psychiatry. 2014 May;75(5):e441-9. doi: 10.4088/JCP.13r08672.

PMID:
24922496
[PubMed - indexed for MEDLINE]
3.

A Review of the Risk of QT/QTc Prolongation Among Newer Non-SSRI Antidepressants.

Jasiak NM, Bostwick JR.

Ann Pharmacother. 2014 Sep 9. pii: 1060028014550645. [Epub ahead of print] Review.

PMID:
25204465
[PubMed - as supplied by publisher]
4.

QTc prolongation, torsades de pointes, and psychotropic medications.

Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC.

Psychosomatics. 2013 Jan-Feb;54(1):1-13. doi: 10.1016/j.psym.2012.11.001. Review.

PMID:
23295003
[PubMed - indexed for MEDLINE]
5.

Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?

Vieweg WV, Hasnain M, Howland RH, Hettema JM, Kogut C, Wood MA, Pandurangi AK.

Am J Med. 2012 Sep;125(9):859-68. doi: 10.1016/j.amjmed.2011.12.002. Epub 2012 Jun 27. Review.

PMID:
22748401
[PubMed - indexed for MEDLINE]
6.

Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: a case report and literature review.

Tseng PT, Lee Y, Lin YE, Lin PY.

Gen Hosp Psychiatry. 2012 Mar-Apr;34(2):210.e13-5. doi: 10.1016/j.genhosppsych.2011.10.005. Epub 2011 Nov 30. Review.

PMID:
22133983
[PubMed - indexed for MEDLINE]
7.

Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reports.

Kogut C, Crouse EB, Vieweg WV, Hasnain M, Baranchuk A, Digby GC, Koneru JN, Fernandez A, Deshmukh A, Hancox JC, Pandurangi AK.

Ther Adv Drug Saf. 2013 Oct;4(5):189-98. doi: 10.1177/2042098613492366.

PMID:
25114780
[PubMed]
Free PMC Article
8.

QT interval prolongation in users of selective serotonin reuptake inhibitors in an elderly surgical population: a cross-sectional study.

van Haelst IM, van Klei WA, Doodeman HJ, Warnier MJ, De Bruin ML, Kalkman CJ, Egberts TC.

J Clin Psychiatry. 2014 Jan;75(1):15-21. doi: 10.4088/JCP.13m08397.

PMID:
24345304
[PubMed - indexed for MEDLINE]
9.

Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.

Vieweg WV, Wood MA, Fernandez A, Beatty-Brooks M, Hasnain M, Pandurangi AK.

Drugs Aging. 2009;26(12):997-1012. doi: 10.2165/11318880-000000000-00000. Review.

PMID:
19929028
[PubMed - indexed for MEDLINE]
10.

Systematic review and guide to selection of selective serotonin reuptake inhibitors.

Edwards JG, Anderson I.

Drugs. 1999 Apr;57(4):507-33. Erratum in: Drugs 1999 Dec;58(6):1207-9.

PMID:
10235690
[PubMed - indexed for MEDLINE]
11.

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.

Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M.

Clin Ther. 2009 Jun;31 Pt 1:1426-53. doi: 10.1016/j.clinthera.2009.07.009. Review.

PMID:
19698902
[PubMed - indexed for MEDLINE]
12.

QT alterations in psychopharmacology: proven candidates and suspects.

Alvarez PA, Pahissa J.

Curr Drug Saf. 2010 Jan;5(1):97-104. Review.

PMID:
20210726
[PubMed - indexed for MEDLINE]
13.
14.

Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose.

Isbister GK, Bowe SJ, Dawson A, Whyte IM.

J Toxicol Clin Toxicol. 2004;42(3):277-85.

PMID:
15362595
[PubMed - indexed for MEDLINE]
15.

Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports.

Vieweg WV, Hasnain M, Hancox JC, Baranchuk A, Digby GC, Kogut C, Crouse EL, Koneru JN, Deshmukh A, Pandurangi AK.

Psychopharmacology (Berl). 2013 Aug;228(4):515-24. doi: 10.1007/s00213-013-3192-8. Epub 2013 Jun 30. Review.

PMID:
23812796
[PubMed - indexed for MEDLINE]
16.

Protease inhibitor-associated QT interval prolongation.

Hunt K, Hughes CA, Hills-Nieminen C.

Ann Pharmacother. 2011 Dec;45(12):1544-50. doi: 10.1345/aph.1Q422. Epub 2011 Nov 29. Review.

PMID:
22128044
[PubMed - indexed for MEDLINE]
17.

A critical evaluation of the cardiac toxicity of citalopram: part 1.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2011 Nov;49(11):13-6. doi: 10.3928/02793695-20111011-01. Epub 2011 Oct 19.

PMID:
22007855
[PubMed - indexed for MEDLINE]
18.

A question about the potential cardiac toxicity of escitalopram.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2012 Apr;50(4):17-20. doi: 10.3928/02793695-20120307-02. Epub 2012 Mar 14.

PMID:
22421011
[PubMed - indexed for MEDLINE]
19.

Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.

Baumann P.

Clin Pharmacokinet. 1996 Dec;31(6):444-69. Review.

PMID:
8968657
[PubMed - indexed for MEDLINE]
20.

[The transfer of selective serotonin reuptake inhibitors to human milk].

Nordeng H, Bergsholm YK, Bøhler E, Spigset O.

Tidsskr Nor Laegeforen. 2001 Jan 20;121(2):199-203. Norwegian.

PMID:
11475200
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk